We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+11.51%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$298M
AUM Growth
+$10.1M
Cap. Flow
-$16.4M
Cap. Flow %
-5.52%
Top 10 Hldgs %
49.9%
Holding
563
New
25
Increased
32
Reduced
140
Closed
10

Top Buys

Rank Stock Value
1
QYLD icon
Global X NASDAQ-100 Covered Call ETF
QYLD
+$225K
2
AGNC icon
AGNC Investment
AGNC
+$174K
3
FTSM icon
First Trust Enhanced Short Maturity ETF
FTSM
+$144K
4
XRPI
Volatility Shares Trust XRP ETF
XRPI
+$120K
5
PANW icon
Palo Alto Networks
PANW
+$81K

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.97M
2
AVGO icon
Broadcom
AVGO
+$2.92M
3
SFM icon
Sprouts Farmers Market
SFM
+$1.58M
4
AAPL icon
Apple
AAPL
+$1.29M
5
MEDP icon
Medpace
MEDP
+$656K

Sector Composition

Rank Sector Weight
1 Technology 52.69%
2 Healthcare 7.58%
3 Consumer Staples 6.4%
4 Industrials 5.7%
5 Financials 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYX icon
526
NCR Voyix
VYX
$1.06B
$151 ﹤0.01%
12
– –
TLRY icon
527
Tilray
TLRY
$479M
$144 ﹤0.01%
8
– –
ARKG icon
528
ARK Genomic Revolution ETF
ARKG
$1.51B
$139 ﹤0.01%
5
– –
POCI icon
529
Precision Optics
POCI
$47.1M
$113 ﹤0.01%
26
-13
-33% -$61
XRX icon
530
Xerox
XRX
$337M
$95 ﹤0.01%
25
– –
XYZ
531
Block Inc
XYZ
$45.9B
$72 ﹤0.01%
1
– –
LUV icon
532
Southwest Airlines
LUV
$22B
$64 ﹤0.01%
2
– –
F icon
533
Ford
F
$57.3B
$60 ﹤0.01%
5
– –
CNDT icon
534
Conduent
CNDT
$230M
$56 ﹤0.01%
20
– –
LUMN icon
535
Lumen
LUMN
$6.53B
$43 ﹤0.01%
7
– –
VTRS icon
536
Viatris
VTRS
$20.1B
$42 ﹤0.01%
4
-2
-33% -$19
TVRD
537
Tvardi Therapeutics
TVRD
$23.5M
$39 ﹤0.01%
1
– –
OGN icon
538
Organon & Co
OGN
$3.55B
$27 ﹤0.01%
3
– –
NOTE
539
DELISTED
FiscalNote
NOTE
$14 ﹤0.01%
+3
New +$19
CHRN
540
ChronoScale Holdings
CHRN
$3.12B
$5 ﹤0.01%
1
– –
AGEN
541
Agenus
AGEN
$249M
$4 ﹤0.01%
1
-1
-50% -$5
CENN icon
542
Cenntro
CENN
$8.23M
– –
0
– –
RLMD icon
543
Relmada Therapeutics
RLMD
$544M
$4 ﹤0.01%
2
-1
-33% -$1
CRDF icon
544
Cardiff Oncology
CRDF
$64.3M
$2 ﹤0.01%
1
– –
FRC
545
DELISTED
First Republic Bank
FRC
$1 ﹤0.01%
325
– –
ALX
546
Alexander's
ALX
$1.4B
– –
-50
Closed -$11.3K
B
547
Barrick Mining
B
$62.2B
– –
-20
Closed -$416
GTBP icon
548
GT Biopharma
GTBP
$11.7M
– –
-1
Closed -$4
HOOD icon
549
Robinhood
HOOD
$85.2B
– –
-30
Closed -$2.81K
IDXX icon
550
Idexx Laboratories
IDXX
$42.9B
– –
-40
Closed -$21.5K
19 20 21
22
23

Similar funds

SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RHP
Royal Harbor Partners Houston, Texas $295M AUM 14.06% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
RLIM
Red Lighthouse Investment Management New York $296M AUM 22.04% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $296M AUM 24.47% 1-Year Est. Return
CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $297M AUM 24.5% 1-Year Est. Return
MFC
Morris Financial Concepts Mount Pleasant, South Carolina $295M AUM 17.25% 1-Year Est. Return

Front Row Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Front Row Advisors held 563 positions worth $298M, up 3.5% from $287M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Front Row Advisors withdrew a net $16.4M in Q3 2025, closing 10 positions and reducing 140 holdings. Its most notable exit was Idexx Laboratories, an estimated $21.5K position sold in full.

By sector, the portfolio is most concentrated in Technology at 53% of assets, up from 50% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Front Row Advisors opened a new position in Volatility Shares Trust XRP ETF worth $112K.

  • Front Row Advisors's largest Q3 2025 buy was Volatility Shares Trust XRP ETF: 6,500 shares worth $112K.
  • Front Row Advisors added most to Global X NASDAQ-100 Covered Call ETF in Q3 2025, an estimated $225K increase.
  • Front Row Advisors's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $3.97M.
  • Front Row Advisors fully exited Idexx Laboratories in Q3 2025, selling an estimated $21.5K.
  • Front Row Advisors's ten largest holdings make up 50% of its $298M portfolio in Q3 2025.
  • Front Row Advisors opened 25 new positions and closed 10 in Q3 2025.
  • Front Row Advisors's portfolio value rose 3.5% quarter-over-quarter to $298M.

Based on Front Row Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.